US Stock MarketDetailed Quotes

TFX Teleflex

Watchlist
  • 135.130
  • +2.380+1.79%
Close Mar 3 16:00 ET
  • 135.130
  • 0.0000.00%
Post 16:20 ET
6.27BMarket Cap91.30P/E (TTM)

About Teleflex Company

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia, and Original Equipment Manufacturer and Development Services (OEM). The Americas, EMEA, and Asia segments are involved in the design, manufacture, and distribution of medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The OEM segment refers to the design, manufacture, and supply of devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Company Profile

SymbolTFX
Company NameTeleflex
Listing DateApr 28, 1994
Founded1943
CEOMr. Liam J. Kelly
MarketNYSE
Employees14100
Fiscal Year Ends12-31
Address550 East Swedesford Road,Suite 400
CityWayne
ProvincePennsylvania
CountryUnited States of America
Zip Code19087
Phone1-610-225-6800

Company Executives

  • Name
  • Position
  • Salary
  • Liam J. Kelly
  • Chairman of the Board, President and Chief Executive Officer
  • 9.04M
  • Thomas E. Powell
  • Executive Vice President and Chief Financial Officer
  • 2.60M
  • John R. Deren
  • Corporate Vice President and Chief Accounting Officer
  • --
  • Cameron P. Hicks
  • Corporate Vice President, Human Resources and Communications
  • --
  • James Winters
  • Corporate Vice President, Manufacturing and Supply Chain
  • 1.62M
  • Jay White
  • Corporate Vice President and President, Global Commercial
  • 2.37M
  • Daniel V. Logue
  • Corporate Vice President, General Counsel and Secretary
  • 1.81M
  • Gretchen R. Haggerty
  • Independent Director
  • 308.20K
  • Andrew A. Krakauer
  • Independent Director
  • 308.28K
  • John C. Heinmiller
  • Independent Director
  • 308.20K
  • Stuart A. Randle
  • Independent Director
  • 324.53K
  • Dr. Stephen K. Klasko
  • Lead Independent Director
  • 350.30K
  • Dr. Jaewon Ryu, J.D.,M.D.
  • Independent Director
  • 364.30K
  • Candace H. Duncan
  • Independent Director
  • 331.70K
  • Neena M. Patil
  • Independent Director
  • 301.20K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More